Charles River Laboratories International (CRL) Equity Income (2012 - 2016)

Charles River Laboratories International (CRL) has reported Equity Income for 5 consecutive years, with $442000.0 the latest figure, recorded in Q3 2016.

• In Q3 2016, Equity Income fell 86.36% year-over-year to $442000.0; the TTM figure through Sep 2016 stood at $8.7 million (up 58.08% YoY), while the FY2015 annual figure was $3.8 million, down 58.89% from the prior year.
• Equity Income came in at $442000.0 for Q3 2016 at Charles River Laboratories International, down from $5.0 million in the prior quarter.
• The five-year high for Equity Income was $6.1 million in Q1 2014, with the low at -$907000.0 in Q2 2015.
• Average Equity Income over 5 years is $1.4 million, with a median of $1.1 million recorded in 2013.
• Across the five-year window, Equity Income surged 6882.22% in 2014 and sank 143.69% in 2015, its largest moves.
• Year by year, Equity Income stood at -$373000.0 in 2012, then surged by 386.33% to $1.1 million in 2013, then surged by 80.06% to $1.9 million in 2014, then tumbled by 88.61% to $219000.0 in 2015, then surged by 101.83% to $442000.0 in 2016.
• According to Business Quant data, Equity Income over the past three periods registered $442000.0, $5.0 million, and $3.1 million for Q3 2016, Q2 2016, and Q1 2016 respectively.